Inter Pharma PCL
SET:IP
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.3
6.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Inter Pharma PCL
Total Liabilities & Equity
Inter Pharma PCL
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inter Pharma PCL
SET:IP
|
Total Liabilities & Equity
฿3B
|
CAGR 3-Years
57%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
D
|
Do Day Dream PCL
SET:DDD
|
Total Liabilities & Equity
฿5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Thai Nippon Rubber Industry PCL
SET:TNR
|
Total Liabilities & Equity
฿2.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
K
|
Karmarts PCL
SET:KAMART
|
Total Liabilities & Equity
฿4.6B
|
CAGR 3-Years
45%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
|
A
|
Asian Phytoceuticals PCL
SET:APCO
|
Total Liabilities & Equity
฿615m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
D
|
DOD Biotech PCL
SET:DOD
|
Total Liabilities & Equity
฿1.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Inter Pharma PCL
Glance View
Inter Pharma PCL is engaged in biopharmaceutical business. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2019-11-05. The firm is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. The firm provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company’s animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. The company also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., Modern Pharma Co., Ltd. and Inter Petrina Co., Ltd.
See Also
What is Inter Pharma PCL's Total Liabilities & Equity?
Total Liabilities & Equity
3B
THB
Based on the financial report for Dec 31, 2023, Inter Pharma PCL's Total Liabilities & Equity amounts to 3B THB.
What is Inter Pharma PCL's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
72%
Over the last year, the Total Liabilities & Equity growth was -4%. The average annual Total Liabilities & Equity growth rates for Inter Pharma PCL have been 57% over the past three years , 72% over the past five years .
You don't have any saved screeners yet
